Grant: Operating Grant
Université de Montréal
$739,210.00
Cholinergic enhancement of visual capacity in rodents
EF 2010-11
Résumé
Because vision is not only a matter of eyes, the proposed research studies how the neurons in the brain could improve vision. The final objective is to find new pharmacological agents to alleviate visual deficits.
The research particularly focuses on acetylcholine (ACh), a chemical substance secreted by certain neurons in the brain to communicate with each other. It is hypothesized that ACh could enhance the functioning of the region of the brain where visual information is first analyzed (named primary visual cortex or V1). The role of ACh in vision was examined because this neurochemical plays an active role in attention, learning and memory. The involvement of ACh in visual learning implies that this neurochemical facilitates the recognition of visual elements in a scene by increasing the rapidity and the efficiency of V1 to analyze these particular elements. We have already shown that ACh enhances the responses of the V1 neurons in rats to visual stimulation in a very persistent manner. Now the proposed experiments will examine the capacity of a repetitive exposition (during 2 weeks) of the rats to a visual pattern in combination to ACh circuit activation to improve permanently vision, electrical activity and neuronal circuits in V1. This is tested in normal animals as well as in animals with a retinal lesion to investigate whether a treatment with ACh contributes to the recovery of vision.
First, these groups of rats will be tested in a maze in order to recognize the pattern to which they have been exposed regularly. Electrical activity in V1 will be measured by a technique similar to electroencephalography and the neuronal circuits will be analyzed on brain slices by microscopy. Finally, cerebral imaging will be used to observe the changes induced by the training on the representation of the pattern in V1.
This study should provide new findings in order to potentiate the rehabilitation therapy to recover visual capacities by low vision people.
Programme
Operating Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
210023
Name
Vaucher Elvire
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Behavioural Sciences - A: Neurobiological Basis of Behavioural Processes
Projecttitle
Cholinergic enhancement of visual capacity in rodents
Programtype2
Operating Grants
Orgnameinp2
Université de Montréal
Cihramount2
$739,210
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Acetylcholine; Cerebral Cortex; Functional Neuroanatomy; Neuronal Plasticity; Vision Recovery; Visual Discrimination
Abstract
Because vision is not only a matter of eyes, the proposed research studies how the neurons in the brain could improve vision. The final objective is to find new pharmacological agents to alleviate visual deficits.
The research particularly focuses on acetylcholine (ACh), a chemical substance secreted by certain neurons in the brain to communicate with each other. It is hypothesized that ACh could enhance the functioning of the region of the brain where visual information is first analyzed (named primary visual cortex or V1). The role of ACh in vision was examined because this neurochemical plays an active role in attention, learning and memory. The involvement of ACh in visual learning implies that this neurochemical facilitates the recognition of visual elements in a scene by increasing the rapidity and the efficiency of V1 to analyze these particular elements. We have already shown that ACh enhances the responses of the V1 neurons in rats to visual stimulation in a very persistent manner. Now the proposed experiments will examine the capacity of a repetitive exposition (during 2 weeks) of the rats to a visual pattern in combination to ACh circuit activation to improve permanently vision, electrical activity and neuronal circuits in V1. This is tested in normal animals as well as in animals with a retinal lesion to investigate whether a treatment with ACh contributes to the recovery of vision.
First, these groups of rats will be tested in a maze in order to recognize the pattern to which they have been exposed regularly. Electrical activity in V1 will be measured by a technique similar to electroencephalography and the neuronal circuits will be analyzed on brain slices by microscopy. Finally, cerebral imaging will be used to observe the changes induced by the training on the representation of the pattern in V1.
This study should provide new findings in order to potentiate the rehabilitation therapy to recover visual capacities by low vision people.
Competitiondate
201009
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Vaucher, Elvire
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $739,210~ $0~